We are driving innovation with industry and manufacturing partners to transform industries and deliver growth to our economies, thereby helping to improve people’s livelihoods.
We are improving the health of people across the world through new discoveries, treatments and patient pathways and working in partnership to build a transformative health ecosystem in our region.
We are working to understand the impact of climate change on the planet and its people, to improve air quality, and developing new technologies to decarbonise energy and transport in partnership with industry and government.
We are working with our partners to tackle inequalities in all aspects of society, striving to make change for a fairer world and one in which people can enjoy a fulfilling, rewarding life.
We explore what it means to be human – in historical and cultural contexts, within ethical and legal norms and through languages and communication.
From atoms to astronomy, computers to cars and robots to robust materials, our goal is to transform our understanding of the world to make life easier, healthier and more sustainable.
Across the breadth of life and environmental sciences, we discover, apply and translate science to forge major advances in human and environmental health.
With more than 1,000 academic staff researchers and around £80 million new research funding per year, we are dedicated to performing world-leading research with the ultimate goal of improving human health.
We address the challenges facing society and the economy, from shedding light on the refugee crisis, to character education in schools, through to developing leaders in the NHS.
The Centre for Advanced Therapies Manufacturing Training is a newly established National Training Centre based in Birmingham, UK. We are one of several National Training Centres that are part of the Advanced Therapies Skills and Training Network (ATSTN), which is coordinated by the Cell and Gene Therapy Catapult.
The Centre for Advanced Therapies Manufacturing Training is part of the ATSTN programme funded from the Department of Business, Energy & Industrial Strategy (BEIS) and Innovate UK (IUK), coordinated by the Cell and Gene Therapy Catapult.